CHENGDU, Dec. 21 (Xinhua) Two-and-half-year-old Xuanxuan survived a rare kidney disease in early December, thanks to fast-track approval of the transplant. T
Big Pharma's cancer immunotherapies were once again excluded from China's national reimbursement. Biocon and Viatris are reportedly considering combining their biosimilar operations. A Chinese oncology biotech just secured a handsome $200 million series A. And more.
Pobeda posle cele decenije borbe, još je jača, lepša i nestvarnija. To najbolje znaju devojčica Anđela Dimitrijević (14), koja boluje od spinalne mišićne atrofije tip 2 i njena majka Svetlana, koja je svojoj ćerki bila najveći oslonac i motivator, u onim trenucima kada bi potonula.
New data analysis suggests an investigational higher dose of SPINRAZA may lead to clinically meaningful improvements in motor functionA NURTURE study analysis shows 92 percent of children who initiated